Tag: Bayer
Supreme Court case could shield Monsanto from cancer lawsuits and reshape...
A Supreme Court fight over Roundup warning labels could determine whether injured Americans can continue challenging pesticide manufacturers in court, while raising far-reaching questions about federal power, corporate liability, and public health protections.
Trump DOJ backs Bayer in Supreme Court fight over Roundup cancer...
A move by the administration aligns federal power with pesticide manufacturers as thousands of cancer patients fight for their day in court.
Monsanto to pay $2.1 billion in Roundup herbicide lawsuit filed in...
This is the latest court battle Monsanto has faced over its herbicide.
Monsanto drops lawsuits against Mexican government over its genetically modified corn...
Several lawsuits were initiated in response to President Andrés Manuel López Obrador 2020 presidential decree, which aimed to ban glyphosate and genetically modified (GM) corn for human consumption.
Washington court reverses verdict against Bayer in PCBs case
A $185 million verdict against Pharmacia—a Monsanto spinoff—which sold now-banned chemicals called polychlorinated biphenyls (PCBs), was found liable in 2021 for chemical contamination.
Jury hands down $2.25 billion verdict to Bayer in Roundup weed...
John McKivison sued Bayer because he believes he developed cancer after using Roundup on his property for two decades,
A poisoned legacy: challenging the EPA’s reluctance to ban glyphosate amidst...
Unveiling the controversy: a deep dive into the legal, scientific, and humanitarian debate over glyphosate's future
Glyphosate sales fall as Bayer takes a €2.5 billion hit
A “significant further decline” of glyphosate sales could push Bayer towards a breakup of its agriculture business.
Glyphosate found in more than 80% of U.S. urine samples
Glyphosate was listed as a probable human carcinogen by the World Health Organization’s International Agency for Research on Cancer in 2015.
The rest of the story—Monsanto owner Bayer struggles to shed Roundup...
Monsanto owner, Bayer AG, is contemplating pulling the popular herbicide from the residential market as it struggles to cement a strategy to limit ongoing litigation.
POPULAR
EPA plans to rescind methane Super Emitter Program, citing estimated $45 billion in savings
Administrator Lee Zeldin announced the plan to oil and gas executives in Santa Fe, and the agency's release gives no method for its savings figure.
Companies that saw federal cases dropped gave or pledged $210.5 million to Trump-aligned super...
Public Citizen's tracker lists more than 200 corporations that benefited from canceled enforcement, and the group says its database is not comprehensive.
Ketamine: What to know about the drug at the center of the Cornell case
Ketamine is a powerful drug with promise for treating depression in small doses. Recreational use is risky, especially combined with alcohol.
How Hurricane Isaias broke through to become the first Atlantic hurricane in an eerily...
An atmospheric scientist explains what’s been going on in the atmosphere, and how El Niño and the jet stream both play important roles.
AI, Tech Leaders Are Lobbying Trump Health Officials in a Government-Run Chat Room
A Slack workspace managed by the Centers for Medicare & Medicaid Services has served as an extraordinary war room for AI industry insiders and Trump administration officials to launch a rapid campaign aimed at persuading Americans to manage their healthcare and medical records on apps.